Differential induction of IFN-α and modulation of CD112 and CD54 expression govern the magnitude of NK cell IFN-γ response to influenza A viruses
LM Kronstad, C Seiler, R Vergara… - The Journal of …, 2018 - journals.aai.org
In human and murine studies, IFN-γ is a critical mediator immunity to influenza. IFN-γ
production is critical for viral clearance and the development of adaptive immune responses …
production is critical for viral clearance and the development of adaptive immune responses …
Vaccinating for natural killer cell effector functions
Vaccination has proved to be highly effective in reducing global mortality and eliminating
infectious diseases. Building on this success will depend on the development of new and …
infectious diseases. Building on this success will depend on the development of new and …
Evasion of natural killer cells by influenza virus
H Guo, P Kumar, S Malarkannan - Journal of leukocyte biology, 2011 - academic.oup.com
ABSTRACT NK cells are important innate immune effectors during influenza virus infection.
However, the influenza virus seems able to use several tactics to counter NK cell recognition …
However, the influenza virus seems able to use several tactics to counter NK cell recognition …
Defective influenza A virus RNA products mediate MAVS-dependent upregulation of human leukocyte antigen class I proteins
Influenza A virus (IAV) increases the presentation of class I human leukocyte antigen (HLA)
proteins that limit antiviral responses mediated by natural killer (NK) cells, but molecular …
proteins that limit antiviral responses mediated by natural killer (NK) cells, but molecular …
[HTML][HTML] Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection
K Borst, S Flindt, P Blank, PK Larsen, C Chhatbar… - PLoS …, 2020 - journals.plos.org
IFN-γ is an enigmatic cytokine that shows direct anti-viral effects, confers upregulation of
MHC-II and other components relevant for antigen presentation, and that adjusts the …
MHC-II and other components relevant for antigen presentation, and that adjusts the …
NK cell immune responses differ after prime and boost vaccination
JL Palgen, N Tchitchek, N Huot… - Journal of Leukocyte …, 2019 - academic.oup.com
A better understanding of innate responses induced by vaccination is critical for designing
optimal vaccines. Here, we studied the diversity and dynamics of the NK cell compartment …
optimal vaccines. Here, we studied the diversity and dynamics of the NK cell compartment …
[HTML][HTML] Dendritic cell-natural killer cell cross-talk modulates T cell activation in response to influenza A viral infection
AG Harvey, AM Graves, CK Uppalapati… - Frontiers in …, 2022 - frontiersin.org
Influenza viruses lead to substantial morbidity and mortality including~ 3-5 million cases of
severe illness and~ 290,000-650,000 deaths annually. One of the major hurdles regarding …
severe illness and~ 290,000-650,000 deaths annually. One of the major hurdles regarding …
Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza
Several studies have highlighted the importance of murine natural killer (NK) cells in the
control of influenza virus infection, notably through the natural cytotoxicity receptor NKp46 …
control of influenza virus infection, notably through the natural cytotoxicity receptor NKp46 …
Natural killer cell dysfunction during acute infection with foot-and-mouth disease virus
Natural killer (NK) cells provide one of the initial barriers of cellular host defense against
pathogens, in particular intracellular pathogens. The role of these cells in foot-and-mouth …
pathogens, in particular intracellular pathogens. The role of these cells in foot-and-mouth …
[HTML][HTML] CAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferrets
CJM Martel, EM Agger, JJ Poulsen… - PLoS …, 2011 - journals.plos.org
Trivalent inactivated vaccines (TIV) against influenza are given to 350 million people every
year. Most of these are non-adjuvanted vaccines whose immunogenicity and protective …
year. Most of these are non-adjuvanted vaccines whose immunogenicity and protective …